Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Mylan Products Ltd., 20 Station Close, Potters Bar, Herts, EN6 1TL, United Kingdom
Arythmol 150 mg Tablets.
| Pharmaceutical Form |
|---|
|
White to off white film coated tablets, biconvex, Face 1: “150”; Face 2: Blank. |
Each tablet contains 150 mg propafenone HCl.
Excipients: Each 150 mg tablet contains up to 10.0 mg sodium.
| Active Ingredient | Description | |
|---|---|---|
| Propafenone |
Propafenone is a class IC anti-arrhythmic agent. It has a stabilising action on myocardial membranes, reduces the fast inward current carried by sodium ions with a reduction in depolarisation rate and prolongs the impulse conduction time in the atrium, AV node and primarily, in the His-Purkinje system. |
| List of Excipients |
|---|
|
Microcrystalline cellulose |
PVC/aluminium blister strips containing 90 tablets.
Mylan Products Ltd., 20 Station Close, Potters Bar, Herts, EN6 1TL, United Kingdom
PL 46302/0001
5 December 2001
| Drug | Countries | |
|---|---|---|
| ARYTHMOL | United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
